Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Research reinforces link between gut microbiome and autism
June 2018
SHARING OPTIONS:

BOSTON & PASADENA, Calif.—Axial Biotherapeutics shared data at the recent International Society for Autism Research conference regarding the link between the gut microbiome and autism spectrum disorder (ASD). Axial found that concentrations of 4-ethylphenylsulfate (4-EPS), a bacterial metabolite, were as much as sixfold higher in serum samples from children with ASD compared to healthy controls in replicate analyses. Previous work by Dr. Sarkis Mazmanian, co-founder of Axial, demonstrated causality between 4-EPS and anxiety-like behaviors in a “maternal immune activation” mouse model of ASD.
 
“Our clinical biomarker results, derived from one of the largest ASD serum metabolomics studies conducted to date, are encouraging,” said Axial co-founder and CEO Dr. David H. Donabedian. “These data, which are the first we have presented from our ASD program, present a major advancement in our mission to develop microbiome-inspired therapeutics as a potential new approach to treating neurological diseases and disorders like ASD.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.